Showing all 19 results
Dapagliflozin Tablets
FreeProduct Composition & Strength
We supply this product as a Precision-Blended, Hydrolytically Shielded Microdose Tablet, packed exclusively in highly secure, moisture-resistant Alu-Alu blister strips to ensure the absolute chemical stability of the sensitive propanediol monohydrate active ingredient.
Active Ingredient Strength Primary Clinical Function Dapagliflozin (as Propanediol Monohydrate) USP/Ph.Eur. 5 mg The Titration & Hepatic Anchor: The definitive starting dose utilized for patients with severe hepatic impairment or those at high risk for volume depletion (hypotension). Dapagliflozin (as Propanediol Monohydrate) USP/Ph.Eur. 10 mg The Cardio-Renal Macrodose: The massive, globally standardized therapeutic payload required for the aggressive, daily maintenance of Heart Failure, CKD, and Type 2 Diabetes. Excipients Microcrystalline Cellulose / Anhydrous Lactose / Crospovidone / Silicon Dioxide / Magnesium Stearate / Premium Polymeric Film Diluent / Densifier / Superdisintegrant / Glidant / Heavy Film-Coating (Engineered specifically utilizing Strict Low-Humidity Granulation to prevent the highly sensitive API from degrading during compression, sealed with an impenetrable film-coat to block environmental moisture and ensure rapid gastric dissolution) *Pack Sizes: 10×10 Alu-Alu Blisters or 14/28-Tablet Calendar Packs (Optimized specifically for strict chronic cardio-renal dispensing regimens).
Desmopressin Tablets
FreeProduct Composition & Strength
We supply this product as a Precision-Blended, Extreme Microdose Peptide Tablet, packed exclusively in highly secure, moisture-resistant heavy-gauge HDPE bottles or Alu-Alu blister strips to ensure the absolute chemical stability of the fragile acetate salt.
Active Ingredient Strength Primary Clinical Function Desmopressin Acetate USP/Ph.Eur.
(Equivalent to Desmopressin base)0.1 mg The Titration & Pediatric Anchor: The definitive starting dose utilized for primary nocturnal enuresis in children or baseline control of Central Diabetes Insipidus. Desmopressin Acetate USP/Ph.Eur. 0.2 mg The Maintenance Macrodose: High-efficacy therapeutic payload utilized for severe, refractory polyuria and nocturia in adults. Excipients Lactose Monohydrate / Potato Starch / Povidone K-30 / Magnesium Stearate Diluent / Disintegrant / Binder / Lubricant (Engineered specifically utilizing Strict Geometric Dilution to ensure the microscopic peptide payload is flawlessly uniform, manufactured under stringent low-moisture conditions to prevent hydrolytic degradation of the fragile peptide bonds) *Pack Sizes: Heavy-Gauge HDPE Bottles of 30/100 or 10×10 Alu-Alu Blisters (Optimized specifically for strict chronic endocrine dispensing regimens).
Ethinyestradiol Tablets
FreeProduct Composition & Strength
We supply this product as a Precision-Blended, Hazard-Shielded Film-Coated Tablet, packed exclusively in highly secure, moisture-resistant Alu-PVC or Alu-Alu blister strips to ensure the absolute chemical stability of the synthetic steroidal API.
Active Ingredient Strength Primary Clinical Function Ethinylestradiol USP/Ph.Eur. 0.05 mg (50 mcg) The Endocrinology Standard: The definitive micro-dose engineered specifically for female hypogonadism, primary ovarian failure, and strictly monitored estrogen replacement. Ethinylestradiol USP/Ph.Eur. 1 mg The Palliative Oncology Macrodose: Massive therapeutic payload utilized strictly for the aggressive hormonal suppression of advanced, inoperable prostate or breast cancer. Excipients Lactose Monohydrate / Microcrystalline Cellulose / Croscarmellose Sodium / Povidone K-30 / Magnesium Stearate / Premium Polymeric Film Diluent / Binder / Superdisintegrant / Lubricant / Heavy Film-Coating (Engineered specifically to form an impenetrable physical barrier over the tablet core. This completely seals the potent steroidal API, ensuring absolute safety for handlers and guaranteeing zero cross-contamination in the facility) *Pack Sizes: 10×10 Blisters or Bottles of 100 (Optimized specifically for strict chronic endocrine and oncology dispensing regimens).
Glibenclamide, Metformin & Pioglitazone Tablets
FreeProduct Composition & Strength
We supply this product as a Precision-Blended, High-Density Film-Coated Tablet, packed exclusively in highly secure, moisture-resistant Alu-Alu blister strips to ensure the absolute chemical stability of the three highly reactive APIs.
Active Ingredient Strength Primary Clinical Function Glibenclamide USP/Ph.Eur. 5 mg The Secretagogue (Micro-Dose): Triggers rapid, potent insulin release from the pancreas to control acute post-prandial (after-meal) glucose spikes. Pioglitazone (as Hydrochloride) USP/Ph.Eur. 15 mg The Sensitizer (Micro-Dose): Reverses deep cellular insulin resistance in skeletal muscle and adipose tissue. Metformin Hydrochloride USP/Ph.Eur. 500 mg (IR or ER) The Hepatic Anchor (Macro-Dose): Provides baseline suppression of liver glucose production. Frequently formulated in a sustained-release matrix to minimize severe GI side effects. Excipients Microcrystalline Cellulose / Croscarmellose Sodium / Hypromellose / Magnesium Stearate / Premium Opadry Film Diluent / Superdisintegrant / Binder (ER Polymer) / Lubricant (Engineered utilizing elite multi-stage geometric dilution to guarantee that the lethal 5mg micro-dose of Glibenclamide is flawlessly and evenly distributed throughout the massive 500mg Metformin matrix) *Pack Sizes: 10×10 Alu-Alu Blisters (Optimized specifically for strict, chronic diabetic dispensing regimens).
Linagliptin & Metformin Tablets
FreeProduct Composition & Strength
We supply this product as a Precision-Engineered, API-Segregated Bilayer Tablet, packed exclusively in highly secure, moisture-resistant Alu-Alu blister strips or heavy-gauge HDPE bottles to ensure the absolute chemical stability of the highly hygroscopic combination.
Active Ingredient Strength Primary Clinical Function Linagliptin / Metformin HCl (IR) 2.5 mg / 500 mg
2.5 mg / 850 mg
2.5 mg / 1000 mgTwice-Daily Standard: Immediate-release units designed to be taken twice a day with meals to provide rapid, meal-time incretin spikes alongside baseline hepatic suppression. Linagliptin / Metformin HCl (ER) 5 mg / 1000 mg (ER) Once-Daily Premium Standard: High-efficacy Extended-Release therapy designed for ultimate patient compliance, delivering the full daily dose of Linagliptin while slowly trickling Metformin into the gut over 24 hours to prevent severe gastrointestinal side effects. Excipients Hypromellose (HPMC) / Copovidone / Microcrystalline Cellulose / Magnesium Stearate / Premium Moisture-Barrier Film ER Polymer / Binder / Diluent / Lubricant (Engineered utilizing elite Bilayer Rotary Presses to physically separate the delicate 2.5mg/5mg Linagliptin dose from the massive, moisture-drawing Metformin layer, preventing cross-degradation) *Pack Sizes: 10×10 Alu-Alu Blisters or Bottles of 60 (Optimized specifically for strict, massive-volume chronic diabetic dispensing regimens).
Linagliptin Tablets
FreeProduct Composition & Strength
We supply this product as a Precision-Blended, Moisture-Shielded Film-Coated Tablet, packed exclusively in highly secure Alu-Alu blister strips to ensure the absolute chemical stability of the delicate API.
Active Ingredient Strength Primary Clinical Function Linagliptin USP/Ph.Eur. 5 mg The Universal Standard: A single, high-efficacy maintenance dose that applies to all adult patients, regardless of age, hepatic function, or severe renal impairment. Excipients Mannitol / Pregelatinized Starch / Copovidone / Magnesium Stearate / Premium Opadry Film Diluent / Disintegrant / Binder / Moisture-Barrier Coating (Engineered specifically without highly hygroscopic components to prevent moisture absorption, ensuring rapid disintegration and maximum bioavailability of the 5mg payload) *Pack Sizes: 10×10 Alu-Alu Blisters (Optimized specifically for strict, massive-volume chronic diabetic dispensing regimens).
Methimazole Tablets
FreeProduct Composition & Strength
We supply this product as a Precision-Blended, High-Density Tablet, packed exclusively in highly secure, moisture-resistant Alu-PVC or Alu-Alu blister strips to ensure the absolute chemical stability of the thionamide compound.
Active Ingredient Strength Primary Clinical Function Methimazole (Thiamazole) USP/Ph.Eur. 5 mg Maintenance / Titration Standard: Base therapeutic unit for precisely lowering doses as the patient approaches the euthyroid (normal) state, preventing drug-induced hypothyroidism. Methimazole (Thiamazole) USP/Ph.Eur. 10 mg Initial Suppression Standard: High-efficacy adult therapy for rapidly crashing toxic thyroid hormone levels during severe, active hyperthyroidism. Excipients Microcrystalline Cellulose / Lactose Monohydrate / Sodium Starch Glycolate / Magnesium Stearate / Premium Opadry Film Diluent / Binder / Superdisintegrant / Odor-Masking Coating (Engineered specifically using strict geometric dilution to ensure the microscopic API dose is flawlessly distributed, and fi lm-coated to mask the compound’s inherent sulfurous taste) Methyl Cobalmine Tablets
FreeProduct Composition & Strength
We supply this product as a Precision-Blended, Photostable Rapid-Melt Tablet, packed exclusively in highly secure, light-blocking Alu-Alu blister strips to ensure the absolute chemical survival of both the delicate coenzyme and the hyper-hygroscopic ODT matrix.
Active Ingredient Strength Primary Clinical Function Methylcobalamin (Mecobalamin) Ph.Eur./USP 1500 mcg Global Neurology Standard: Mega-dose adult therapy for the aggressive regeneration of peripheral nerves and immediate correction of severe B12 anemia. Excipients Mannitol / Crospovidone / Microcrystalline Cellulose / Sucralose / Premium Cherry or Berry Flavoring / Magnesium Stearate Fast-Dissolving Carrier / Superdisintegrant / Diluent / Sweetener / Masking Agent (Engineered specifically to instantly melt in the saliva within 10 to 30 seconds, creating a highly palatable, sweet liquid that diffuses instantly into the sublingual capillaries) *Pack Sizes: 10×10 Alu-Alu Blisters (Optimized specifically for strict, 3-to-6 month chronic neurology and diabetic dispensing regimens).
Nateglinide Tablets
FreeProduct Composition & Strength
We supply this product as a Precision-Blended, Rapid-Disintegrating Film-Coated Tablet, packed exclusively in highly secure, moisture-resistant Alu-Alu or high-density PVC/PVDC blister strips to ensure the absolute chemical stability of the highly soluble API.
Active Ingredient Strength Primary Clinical Function Nateglinide Ph.Eur./USP 60 mg Initiation / Mild Standard: Base therapeutic unit for patients nearing their HbA1c goal who only require mild postprandial glycemic control. Nateglinide Ph.Eur./USP 120 mg Global Clinical Standard: Primary adult maintenance dose for severe meal-time spikes, taken immediately before the three main meals of the day. Excipients Microcrystalline Cellulose / Croscarmellose Sodium / Povidone K30 / Colloidal Silicon Dioxide / Magnesium Stearate / Premium Opadry Film Diluent / Superdisintegrant / Binder / Glidant (Engineered specifically to shatter and dissolve in the stomach in under 15 minutes, guaranteeing the insulin surge perfectly matches the digestion of the meal) *Pack Sizes: 3×10 or 10×10 Blisters (Optimized specifically for high-turnover diabetic dispensing, as patients consume 3 tablets per day).
Neomercazole Tablets
FreeProduct Composition & Strength
We supply this product as a Precision-Blended Tablet, packed exclusively in highly secure, moisture-resistant Alu-Alu or high-density PVC/PVDC blister strips to ensure the absolute chemical stability of the highly reactive thionamide molecule.
Active Ingredient Strength Primary Clinical Function Carbimazole Ph.Eur./BP 5 mg Maintenance / Titration Standard: Base therapeutic unit for the gradual tapering of therapy and long-term maintenance of euthyroidism. Carbimazole Ph.Eur./BP 10 mg / 20 mg Acute Initiation Standard: High-dose induction therapy to aggressively shut down severe, life-threatening thyrotoxicosis. Excipients Lactose Monohydrate / Maize Starch / Magnesium Stearate / Povidone K30 / Iron Oxide Yellow (for distinct clinical identification) Diluent / Binder / Lubricant (Engineered specifically for rapid, complete gastric dissolution to achieve peak methimazole blood levels within 1 to 2 hours) *Pack Sizes: 10×10 Blisters or Bottles of 100 (Optimized specifically for strict chronic endocrinology dispensing, as patients initiate on high doses and taper down over many months).
Repaglinide & Metformin Tablets
FreeProduct Composition & Strength
We supply this product as a Precision-Engineered Film-Coated Tablet, packed exclusively in highly secure, moisture-resistant Alu-Alu or heavy-density PVC/PVDC blister strips to ensure the absolute chemical stability of the combined formulation.
Active Ingredient Strength Primary Clinical Function Repaglinide USP/Ph.Eur. 1 mg / 2 mg Short-acting meglitinide for rapid post-prandial (after-meal) insulin stimulation. Metformin Hydrochloride USP/Ph.Eur. 500 mg Global Clinical Standard: Biguanide for hepatic glucose suppression and insulin sensitization. Excipients Microcrystalline Cellulose / Povidone K30 / Croscarmellose Sodium / Poloxamer / Magnesium Stearate Diluent / Binder / Superdisintegrant / Surfactant (Engineered for immediate gastric dissolution and synchronized dual-absorption) *Pack Sizes: 10×10 or 3×10 Blisters (Optimized specifically for high-compliance 30-day chronic metabolic dispensing regimens tied directly to meal times).
Repaglinide Tablets
FreeProduct Composition & Strength
We supply this product as a Precision-Engineered Tablet, packed exclusively in highly secure, moisture-resistant Alu-Alu or heavy-density PVC/PVDC blister strips to ensure the absolute chemical stability of the highly sensitive meglitinide API.
Active Ingredient Strength Primary Clinical Function Repaglinide USP/Ph.Eur. 0.5 mg Base titration unit for treatment-naive patients or those with severe renal/hepatic impairment. Repaglinide USP/Ph.Eur. 1 mg / 2 mg Global Clinical Standard: Advanced maintenance doses for rapid post-prandial insulin stimulation. Excipients Microcrystalline Cellulose / Calcium Hydrogen Phosphate / Meglumine / Poloxamer / Magnesium Stearate Diluent / Stabilizer / Surfactant / Lubricant (Engineered for immediate gastric dissolution and ultra-fast systemic absorption) *Pack Sizes: 10×10 or 3×10 Blisters (Optimized specifically for high-compliance 30-day chronic metabolic dispensing regimens tied directly to meal times).
Saxagliptin Tablets
FreeProduct Composition & Strength
We supply this product as a Precision-Blended Film-Coated Tablet, packed exclusively in highly secure, moisture-resistant Alu-Alu blister strips to ensure the absolute chemical stability of the sensitive active pharmaceutical ingredient.
Active Ingredient Strength Primary Clinical Function Saxagliptin (as Hydrochloride) INN/Ph.Eur. 2.5 mg Target dose for patients with moderate/severe renal impairment or those taking strong CYP3A4 inhibitors. Saxagliptin (as Hydrochloride) INN/Ph.Eur. 5 mg Global Clinical Standard: Maximum adult daily dose for the maintenance of Type 2 Diabetes. Excipients Lactose Monohydrate / Microcrystalline Cellulose / Croscarmellose Sodium / Magnesium Stearate Diluent / Binder / Superdisintegrant (Engineered for immediate gastric dissolution and optimal bioavailability) *Pack Sizes: 10×10 Alu-Alu Blisters or 3×10 Unit-Dose Blisters (Optimized specifically for high-compliance 30-day chronic metabolic dispensing regimens).
Teneligliptin & Metformin Tablets
FreeProduct Composition & Strength
We supply this product as a Precision-Blended Bilayer or Matrix Sustained-Release Film-Coated Tablet, packed in highly secure, moisture-resistant Alu-Alu blister strips to ensure the absolute stability of the highly hygroscopic Metformin component.
Active Ingredient Strength Primary Clinical Function Teneligliptin Hydrobromide Hydrate INN 20 mg Immediate-release DPP-4 inhibition for rapid post-prandial (after-meal) glucose control. Metformin Hydrochloride BP/Ph.Eur. 500 mg (Sustained-Release) Continuous 24-hour hepatic glucose suppression and peripheral insulin sensitization. Excipients Hypromellose (HPMC) / Microcrystalline Cellulose / Magnesium Stearate SR Polymer Matrix / Diluent / Lubricant (Engineered for strict 24-hour kinetic release of Metformin) Teneligliptin Tablets
FreeProduct Composition & Strength
We supply this product as a Precision-Blended Film-Coated Tablet, packed in highly secure, moisture-resistant Alu-Alu blister strips to ensure the absolute stability of the active pharmaceutical ingredient across diverse tropical and high-humidity climates.
Active Ingredient Strength Primary Clinical Use Teneligliptin Hydrobromide Hydrate INN 20 mg Standard Global Dose: Once-daily therapy for glycemic control in Type 2 Diabetes. Excipients Microcrystalline Cellulose / Mannitol / Croscarmellose Sodium / Magnesium Stearate Diluent / Superdisintegrant (Engineered for immediate gastric dissolution and rapid absorption) Vildagliptin & Metformin Tablets
FreeProduct Composition & Strength
We supply this product as a highly advanced Film-Coated Tablet (Available in Immediate or Bilayer Sustained-Release formats), packed strictly in high-barrier Alu-Alu blister strips. Alu-Alu packaging is completely non-negotiable, as Vildagliptin is intensely sensitive to moisture degradation.
Active Ingredient Strength & Format Primary Clinical Use Vildagliptin INN/Ph.Eur. 50 mg (Immediate Release Layer) Rapid dissolution to block DPP-4 and manage post-prandial incretin levels. Metformin Hydrochloride USP/BP 500 mg / 850 mg / 1000 mg (IR or SR) Provides continuous baseline hepatic glucose suppression and peripheral sensitization. Excipients Hypromellose (HPMC) / Microcrystalline Cellulose / Titanium Dioxide SR Polymer Matrix / Diluent / Film-Coating (Engineered for precise kinetic release) Vildagliptin Tablets
FreeProduct Composition & Strength
We supply this product as a Precision-Blended Uncoated or Film-Coated Tablet, packed strictly in high-barrier Alu-Alu blister strips to guarantee absolute protection from moisture and environmental degradation.
Active Ingredient Strength Primary Clinical Use Vildagliptin INN/Ph.Eur. 50 mg Standard Adult Dose for monotherapy or adjunctive combination therapy. Excipients Microcrystalline Cellulose / Anhydrous Lactose / Magnesium Stearate Diluent / Lubricant (Engineered for optimal compressibility and rapid gastric dispersion) Voglibose & Metformin Tablets
FreeProduct Composition & Strength
We supply this product as a highly advanced Bilayer Film-Coated Tablet, packed in highly secure, moisture-resistant Alu-Alu blister strips. Alu-Alu packaging is completely non-negotiable, as Voglibose is highly sensitive to moisture degradation.
Active Ingredient Strength & Format Release Profile Function Voglibose USP/BP/JP 0.2 mg / 0.3 mg (Immediate Release Layer) Instantly dissolves in the gut to block carbohydrate absorption during the meal. Metformin Hydrochloride USP/BP 500 mg (Sustained Release Matrix) Slow-release polymer matrix providing continuous 24-hour hepatic suppression. Excipients Hypromellose (HPMC) / Microcrystalline Cellulose SR Polymer Matrix / Diluent (Engineered to control precise dissolution rates) Voglibose Tablet
FreeVoglibose tablets are oral anti-diabetic medications primarily composed of the active ingredient Voglibose, a synthetic alpha-glucosidase inhibitor. They are typically available in strengths of 0.2 mg or 0.3 mg.
